News

Zacks.com on MSN1d
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Tribune Chronicle4d
Prices down for Wegovy and Zepbound
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Many US employers plan to pare health benefits as weight-loss spending soars
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
Honolulu Star-Advertiser2d
Weight-loss drug costs drive employers to trim health benefits
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
Zacks.com on MSN1d
Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
KSL3d
Many employers plan to pare health benefits as weight-loss spending soars
More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...
India Today on MSN1d
US employers to cut health benefits amid soaring weight-loss drug costs: Survey
Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
WGAU Radio1d
FDA reauthorizes Juul e-cigarettes, refills
The FDA announced on Thursday that Juul can keep its products on the market, after the company submitted studies that claim ...
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.